Literature DB >> 33145612

The STK38-XPO1 axis, a new actor in physiology and cancer.

Alexandre Pj Martin1, Vasily N Aushev2, Gérard Zalcman3,4, Jacques H Camonis4.   

Abstract

The Hippo signal transduction pathway is an essential regulator of organ size during developmental growth by controlling multiple cellular processes such as cell proliferation, cell death, differentiation, and stemness. Dysfunctional Hippo signaling pathway leads to dramatic tissue overgrowth. Here, we will briefly introduce the Hippo tumor suppressor pathway before focusing on one of its members and the unexpected twists that followed our quest of its functions in its multifarious actions beside the Hippo pathway: the STK38 kinase. In this review, we will precisely discuss the newly identified role of STK38 on regulating the nuclear export machinery by phosphorylating and activating, the major nuclear export receptor XPO1. Finally, we will phrase STK38's role on regulating the subcellular distribution of crucial cellular regulators such as Beclin1 and YAP1 with its implication in cancer.

Entities:  

Keywords:  Cancer; Hippo; STK38; XPO1; YAP1

Mesh:

Substances:

Year:  2020        PMID: 33145612     DOI: 10.1007/s00018-020-03690-w

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  91 in total

Review 1.  The Hippo Pathway: Biology and Pathophysiology.

Authors:  Shenghong Ma; Zhipeng Meng; Rui Chen; Kun-Liang Guan
Journal:  Annu Rev Biochem       Date:  2019-12-19       Impact factor: 23.643

Review 2.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

3.  The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.

Authors:  Jianbin Huang; Shian Wu; Jose Barrera; Krista Matthews; Duojia Pan
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

Review 4.  The emerging roles of YAP and TAZ in cancer.

Authors:  Toshiro Moroishi; Carsten Gram Hansen; Kun-Liang Guan
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

Review 5.  The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Authors:  Wanjin Hong; Kun-Liang Guan
Journal:  Semin Cell Dev Biol       Date:  2012-05-29       Impact factor: 7.727

Review 6.  Regulation of the Hippo pathway in cancer biology.

Authors:  Sungho Moon; So Yeon Park; Hyun Woo Park
Journal:  Cell Mol Life Sci       Date:  2018-03-30       Impact factor: 9.261

Review 7.  The biology of YAP/TAZ: hippo signaling and beyond.

Authors:  Stefano Piccolo; Sirio Dupont; Michelangelo Cordenonsi
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 8.  The hippo signaling pathway in development and cancer.

Authors:  Duojia Pan
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

Review 9.  YAP/TAZ at the Roots of Cancer.

Authors:  Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

Review 10.  Mechanisms of Hippo pathway regulation.

Authors:  Zhipeng Meng; Toshiro Moroishi; Kun-Liang Guan
Journal:  Genes Dev       Date:  2016-01-01       Impact factor: 11.361

View more
  2 in total

1.  The "STK38-XPO1 axis": its general relevance and mechanistic underpinnings remain to be further characterized.

Authors:  Jose Antonio Rodriguez
Journal:  Cell Mol Life Sci       Date:  2021-02-09       Impact factor: 9.261

2.  Prognostic and Immunological Role of STK38 across Cancers: Friend or Foe?

Authors:  Yankuo Liu; Zhiyuan Shi; Zeyuan Zheng; Jinxin Li; Kunao Yang; Chunlan Xu; Qing Liu; Zhicheng Gong; Yi Yang; Yue Zhao; Zuodong Xuan; Huimin Sun; Chen Shao
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.